9
Participants
Start Date
November 8, 2016
Primary Completion Date
September 18, 2017
Study Completion Date
September 18, 2017
Lactobacillus rhamnosus
The investigators will use Culturelle®, a probiotic composed of the micro-organisms Lactobacillus GG. This formulation has been used for the treatment of gastrointestinal inflammation in numerous clinical trials. Dosing will follow the manufacturer's recommendation for children (1 capsule/packet per day), and will be monitored by the study Co-PI, Dr. Seed. Weekly side effects and clinical changes will be monitored by both study therapist and caregiver using the Children's Global Assessment Scale and the Clinical Global Impression Scale (Severity, Improvement, and Efficacy). The treatment duration is 30 days.
Duke Center for Developmental Epedimiology, Durham
Nancy Zucker
OTHER